SUNDAY, MAY 25, 2025
8:45 am – 9:30 am 

IBD / LIVER
Case Presentations (Interactive)

LIVER Session Learning Objectives

• Enhance Diagnostic Skills: Assist participants in identifying and diagnosing complex liver cases.
• Review Optimal Treatments: Explore the latest treatment options for liver disease management.
• Promote Team-Based Care: Demonstrate how multidisciplinary teams collaborate in treating liver conditions.

IBD Session Learning Objectives:

• Present 2 (or 3) IBD clinical cases
• Present varying treatment considerations and approaches to complex IBD care

Speakers:

Dr. Hemant Shah, MD, MScCH, HOTE, FRCPC

[Liver]

Dr. Hemant Shah is Vice President, Academics at William Osler Health System, an Adjunct Associate Professor at the University of Toronto and a Gastroenterologist and Liver Specialist. Hemant has served in several leadership roles provincially, nationally and internationally. He has designed and delivered many interprofessional education programs and received funding for his innovative chronic and rare disease care models from government, research grant organizations and industry. He has published over 50 peer-reviewed articles, in leading journals such as NEJM, CMAJ, Gastroenterology and including as lead author of the Canadian Consensus Guidelines for Hepatitis C Treatment. He has been honoured for his work as the inaugural recipient of the Canadian Association for the Study of Liver’s Education Excellence Award for contributions to medical education nationally. Dr. Shah is a Fellow of the Royal College of Physicians of Canada, holds a Medical Doctorate and Masters in Community Health from the University of Toronto and an undergraduate degree in Arts and Science from McMaster University.

Dr. Arif Yusuf, MD, FRCPC

Internal Medicine, Gastroenterology
Gastroenterologist, Credit Valley Hospital - Trillium Health Partners
Director - WGTA Research

[IBD]

Arif completed Medicine and Gastroenterology training at University of Toronto, an IBD Fellowship at McMaster University, and currently works at Credit Valley Hospital in Mississauga. He is a co-director at WGTA Research with a focus on IBD clinical trials. 

Panelists:

Dr. Siwar Albashir, MD, FRCPC

Dr. Erin M. Kelley,  MD, MSc., FRCPC

Dr. Marco Puglia, MD, FRCPC

Dr. Marco Puglia, MD,  FRCPC
Associate Professor Medicine
Hepatology and Gastroenterology
McMaster University

Dr. Puglia is an Associate Professor of Medicine at McMaster University and staff Gastroenterologist and Hepatologist at Hamilton Health Sciences. He graduated from medical school at the University of Ottawa. He completed Internal Medicine and Gastroenterology training at McMaster University. He then completed a fellowship in Hepatology and Liver Transplant at the University of Toronto. His clinical interests include the management of viral hepatitis, steatotic liver diseases, pre- and post-liver transplant care as well as general gastroenterology. His academic interests include teaching at both the undergraduate and postgraduate level and participation in several clinical trials in steatotic liver disease, viral hepatitis and cholestatic liver diseases.  

Dr. Parul Tandon, DO, PhD, FRCPC

Staff Gastroenterologist/Clinician Scientist, University Health Network
Assistant Professor, University of Toronto

Dr. Parul Tandon is a staff gastroenterologist and inflammatory bowel diseases specialist at the University Health Network. He completed his internal medicine training at the University of Ottawa and adult gastroenterology residency at the University of Toronto.  Dr. Tandon is a Clinician Scientist and Assistant Professor at the University of Toronto. His research interests include the care of IBD in racial and ethnic minorities as well as access to care for women with IBD during preconception and pregnancy, and for infants born to women with IBD in the first years of life.

Moderator:

Dr. Arif Yusuf, MD, FRCPC